Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Pharmacol.

Sec. Translational Pharmacology

Volume 16 - 2025 | doi: 10.3389/fphar.2025.1632568

This article is part of the Research TopicModel-Informed Approaches: Uniting Drug Development with Personalized MedicineView all articles

Published population pharmacokinetic models of mycophenolate sodium: a systematic review and external evaluation in a Chinese sample of renal transplant recipients

Provisionally accepted
Tong  GaoTong GaoWen  XuWen XuXiao  LiXiao LiQie  GuoQie GuoDonghua  LiuDonghua LiuXiaolei  ZhangXiaolei ZhangPing  LengPing LengJialin  SunJialin Sun*
  • Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, China

The final, formatted version of the article will be published soon.

Background: Immunosuppressive therapy remains the primary method for preventing rejection in renal transplant recipients. While multiple population pharmacokinetic (popPK) models of mycophenolate sodium (MPS) have been developed for this population, their predictive performance across different clinical settings remains unverified. This study systematically evaluated published MPS popPK models through external validation to assess their extrapolation potential. Methods: Published MPS popPK models for renal transplant recipients were identified through systematic searches of PubMed, Embase and Web of Science. These models were externally evaluated using a cohort of renal transplant patients receiving MPS therapy at the Affiliated Hospital of Qingdao University. Model prediction performance was evaluated using three metrics: the goodness-of-fit method based on model prediction, prediction error test method and visual predictive checks method based on model simulation. Results: A total of 186 drug concentration data of 31 patients in our hospital were collected, and 4 literatures were retrieved, among which 1 were one-compartment models and 3 were two-compartment models. In the goodness-of-fit diagnosis and prediction error test based on model prediction, the population prediction data of all models were not good, while the individual prediction data showed that the fitting result of Model 1 was relatively better. The visual prediction test results based on model simulation show that the fitting result of Model 1 was relatively good, while the distribution deviation between the observed data and the simulation data of the remaining models was large, and the fitting effect was not good. Conclusion: The published models exhibit significant variability and unsatisfactory predictive performance, indicating that therapeutic drug monitoring (TDM) remains an essential requirement for the clinical application of MPS. To advance individualized medication for MPS based on popPK, future research must prioritize the investigation of potential covariates. This will enable identification of key factors influencing MPS model predictability and facilitate the development of a popPK model suitable for patients in our hospital.

Keywords: population pharmacokinetics, Mycophenolate sodium, external evaluation, Renal transplant recipients, Therapeutic drug monitoring

Received: 21 May 2025; Accepted: 04 Aug 2025.

Copyright: © 2025 Gao, Xu, Li, Guo, Liu, Zhang, Leng and Sun. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Jialin Sun, Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.